Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Viemed Healthcare Inc VMD

Viemed Healthcare, Inc. through its subsidiaries, is a provider of home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The Company’s service offerings are focused on effective in-home treatment with clinical practitioners providing therapy and counselling to patients in their homes using cutting edge technologies. The Company’s products and services... see more

NDAQ:VMD - Post Discussion

Viemed Healthcare Inc > Estimated Core Revenue 2nd Quarter:
View:
Post by LongTerm3 on May 03, 2022 5:58pm

Estimated Core Revenue 2nd Quarter:

$32.45 Million is the midpoint for Core Revenue for the second quarter. That would be up over 23 percent Core year over year.
Comment by donmayne on May 03, 2022 6:25pm
In an earlier post, I had remarked: "Guidance for Q2 will probably be the most important number to look for in the upcoming news release. I am hoping for core revenue guidance to reflect the historic growth rate of 30% (or perhaps higher) per annum on the core revenue...." If they achieve the midpooint guidance of $32.45 million, it would mean a quarterly increase of $2.45 million.  ...more  
Comment by JackLambert on May 03, 2022 7:31pm
Nice pu$$y the talking heads are saying we are now moving from pandemic to epidemic.   Maybe.  We hope.   But we can take comfort from the robust growth in non vent core revenues.   there is enough juice in the margins to allow for some compression.  And five move headcount in April.   Overall there's grounds to breathe easier.    I'm still not ...more  
Comment by JackLambert on May 03, 2022 7:52pm
And the numbers suggest the RTs are below capacity.    Maybe 20%     So we can rapidly add new patients without needing to ramp up or hire.   Will restore margin. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities